GlycoMimetics Inc (GLYC)
0.3898
-0.02
(-4.93%)
USD |
NASDAQ |
Nov 05, 16:00
0.3898
0.00 (0.00%)
After-Hours: 18:26
GlycoMimetics Price to Book Value: 1.253 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 1.318 |
| November 01, 2024 | 1.230 |
| October 31, 2024 | 1.308 |
| October 30, 2024 | 1.467 |
| October 29, 2024 | 1.575 |
| October 28, 2024 | 0.5406 |
| October 25, 2024 | 0.556 |
| October 24, 2024 | 0.5586 |
| October 23, 2024 | 0.5705 |
| October 22, 2024 | 0.5303 |
| October 21, 2024 | 0.5143 |
| October 18, 2024 | 0.5091 |
| October 17, 2024 | 0.5094 |
| October 16, 2024 | 0.5043 |
| October 15, 2024 | 0.4898 |
| October 14, 2024 | 0.4776 |
| October 11, 2024 | 0.4824 |
| October 10, 2024 | 0.4638 |
| October 09, 2024 | 0.4612 |
| October 08, 2024 | 0.4911 |
| October 07, 2024 | 0.5014 |
| October 04, 2024 | 0.5136 |
| October 03, 2024 | 0.5149 |
| October 02, 2024 | 0.495 |
| October 01, 2024 | 0.5329 |
| Date | Value |
|---|---|
| September 30, 2024 | 0.5432 |
| September 27, 2024 | 0.5368 |
| September 26, 2024 | 0.548 |
| September 25, 2024 | 0.5127 |
| September 24, 2024 | 0.5287 |
| September 23, 2024 | 0.5287 |
| September 20, 2024 | 0.5297 |
| September 19, 2024 | 0.5464 |
| September 18, 2024 | 0.5271 |
| September 17, 2024 | 0.5303 |
| September 16, 2024 | 0.5213 |
| September 13, 2024 | 0.5464 |
| September 12, 2024 | 0.5271 |
| September 11, 2024 | 0.522 |
| September 10, 2024 | 0.5101 |
| September 09, 2024 | 0.5249 |
| September 06, 2024 | 0.5049 |
| September 05, 2024 | 0.5291 |
| September 04, 2024 | 0.5168 |
| September 03, 2024 | 0.5467 |
| August 30, 2024 | 0.5667 |
| August 29, 2024 | 0.5567 |
| August 28, 2024 | 0.5464 |
| August 27, 2024 | 0.5785 |
| August 26, 2024 | 0.6075 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4159
Minimum
Jun 16 2022
6.777
Maximum
Apr 01 2024
1.500
Average
1.119
Median
Feb 24 2020
Price to Book Value Benchmarks
| Biomarin Pharmaceutical Inc | 2.326 |
| Arbutus Biopharma Corp | 6.097 |
| FibroGen Inc | -- |
| Cidara Therapeutics Inc | 0.7219 |
| Cue Biopharma Inc | 4.748 |
Price to Book Value Related Metrics
| Price | 0.3898 |
| Earnings Yield | -156.5% |
| Market Cap | 25.14M |